2023
Reducing MRSA Infection in a New NICU During the COVID-19 Pandemic.
Barrett R, Fleiss N, Hansen C, Campbell M, Rychalsky M, Murdzek C, Krechevsky K, Abbott M, Allegra T, Blazevich B, Dunphy L, Fox A, Gambardella T, Garcia L, Grimm N, Scoffone A, Bizzarro M, Murray T. Reducing MRSA Infection in a New NICU During the COVID-19 Pandemic. Pediatrics 2023, 151 PMID: 36625072, DOI: 10.1542/peds.2022-057033.Peer-Reviewed Original ResearchConceptsInvasive MRSA infectionsInfection prevention strategiesMethicillin-resistant Staphylococcus aureusMRSA infectionOutcome measuresPrevention strategiesCOVID-19 pandemicMultidisciplinary quality improvement initiativeLevel IV NICUSubsequent invasive infectionsMRSA colonization rateCoronavirus disease 2019 (COVID-19) pandemicHealthcare Improvement's ModelQuality improvement initiativesDisease 2019 pandemicEffectiveness of interventionsPersonal protective equipmentSupply chain shortagesHospitalized neonatesInvasive infectionsPatient daysSkin colonizationHand hygieneMost NICUsNICU
2012
Baby bottle steam sterilizers disinfect home nebulizers inoculated with bacterial respiratory pathogens
Towle D, Callan DA, Farrel PA, Egan ME, Murray TS. Baby bottle steam sterilizers disinfect home nebulizers inoculated with bacterial respiratory pathogens. Journal Of Cystic Fibrosis 2012, 12: 512-516. PMID: 23267773, DOI: 10.1016/j.jcf.2012.11.013.Peer-Reviewed Original ResearchConceptsHome nebulizersMethicillin-resistant Staphylococcus aureusBacterial respiratory pathogensResistant Staphylococcus aureusNon-mucoid Pseudomonas aeruginosaMucoid Pseudomonas aeruginosaRespiratory pathogensHaemophilus influenzaeBacterial infectionsClinical settingAdditional studiesBacterial growthStaphylococcus aureusStenotrophomonas maltophiliaPseudomonas aeruginosaViable bacteriaTreatmentNebulizerBurkholderia cepaciaInfectionInfluenzae
2011
Low Prevalence of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates among Connecticut Veterans
Fink SL, Martinello RA, Campbell SM, Murray TS. Low Prevalence of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates among Connecticut Veterans. Antimicrobial Agents And Chemotherapy 2011, 56: 582-583. PMID: 22064529, PMCID: PMC3256079, DOI: 10.1128/aac.05024-11.Peer-Reviewed Original ResearchConceptsHeterogeneous vancomycin-intermediate Staphylococcus aureusMethicillin-resistant Staphylococcus aureusHeterogeneous Vancomycin-Intermediate Staphylococcus aureus IsolatesVancomycin-intermediate Staphylococcus aureusLow-prevalence populationsStaphylococcus aureus isolatesStaphylococcus aureusPrevalence populationsRoutine screeningVeterans HospitalLow prevalenceAureus isolatesCurve analysisResistance detectionAureusIsolatesPatientsHospitalPrevalenceEtest